Amanote Research

Amanote Research

    RegisterSign In

The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer

PLoS ONE - United States
doi 10.1371/journal.pone.0046985
Full Text
Open PDF
Abstract

Available in full text

Categories
Multidisciplinary
Date

October 10, 2012

Authors
Lisa M. Privette VinnedgeShuk-Mei HoKathryn A. Wikenheiser-BrokampSusanne I. Wells
Publisher

Public Library of Science (PLoS)


Related search

Targeting the Ron-Dek Signaling Axis in Breast Cancer

2013English

PAK1 Is a Breast Cancer Oncogene That Coordinately Activates MAPK and MET Signaling

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

EN2 Is a Candidate Oncogene in Human Breast Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

Obesity Hormone Leptin: A New Target in Breast Cancer?

Breast Cancer Research
Cancer ResearchOncology
2007English

Estrogen Receptor-Beta Is a Potential Target for Triple Negative Breast Cancer Treatment

Oncotarget
Oncology
2018English

Progesterone Receptor Expression in Proliferating Cancer Cells of Hormone-Receptor-Positive Breast Cancer

Tumor Biology
MedicineCancer Research
2018English

Skp2 Is a Promising Therapeutic Target in Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2012English

Control of Tumorigenesis and Chemoresistance by the DEK Oncogene

Clinical Cancer Research
Cancer ResearchOncology
2010English

Brassinosteroids and Plant Steroid Hormone Signaling

Plant Cell
Plant ScienceCell Biology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy